Search Ontology:
ChEBI

myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]

Term ID
CHEBI:145274
Synonyms
  • 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl 2-O-(6-O-acetyl-beta-D-glucopyranosyl)-6-deoxy-alpha-L-mannopyranoside
  • 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl 2-O-(6-O-acetyl-beta-D-glucopyranosyl)-alpha-L-rhamnopyranoside
  • myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-6-deoxy-alpha-L-mannopyranoside]
  • myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnopyranoside]
Definition
A glycosyloxyflavone that is myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside] in which the hydroxy group at position 6 of the beta-D-glucosyl group has been converted to the corresponding acetate. Identified in PMID: 23549747 Fig. S21 peak 4.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
inverse is_conjugate_base_of
is_conjugate_acid_of
Phenotype
Phenotype resulting from myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]
Phenotype where environments contain myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]
Phenotype modified by environments containing myricetin 3-O-[(6-O-acetyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]
Human Disease / Model Data